In vitro comparison of the complement-scavenging capacity of different intravenous immunoglobulin preparations

Vox Sanguinis

Volumn 97, Issue 4, 2009, Pages 348-354

  Spycher, M ^a   Matozan, K ^b   Minnig, K ^a   Zehnder, R ^a   Miescher, S ^a   Hoefferer, L ^a   Rieben, R ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b CSL Behring AG   (Switzerland)

Author keywords

Complement inhibition; Complement scavenging; Intravenous immunoglobulin; IVIG

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C5A; HUMAN IMMUNOGLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTRATECT; KIOVIG; PRIVIGEN; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; COMPLEMENT INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; IN VITRO SELECTION; NORMAL HUMAN; PRIORITY JOURNAL;

COMPLEMENT ACTIVATION; COMPLEMENT C3A; COMPLEMENT C5A; COMPLEMENT FIXATION TESTS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS;

EID: 70350035637     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2009.01217.x     Document Type: Article

References (20)

1. Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, Kazatchkine MD, Lacroix-Desmazes S, Bayry J, Kaveri SV : Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol 2007 27 : 233 245
2. Debre M, Bonnet MC, Fridman WH, Carosella E, Philippe N, Reinert P, Vilmer E, Kaplan C, Teillaud JL, Griscelli C : Infusion of Fc gamma fragments for treatment of children with acute immune thrombocytopenic purpura. Lancet 1993 342 : 945 949
3. Park-Min KH, Serbina NV, Yang W, Ma X, Krystal G, Neel BG, Nutt SL, Hu X, Ivashkiv LB : FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin. Immunity 2007 26 : 67 78
4. Kaneko Y, Nimmerjahn F, Ravetch JV : Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 2006 313 : 670 673
5. Basta M : Ambivalent effect of immunoglobulins on the complement system: activation versus inhibition. Mol Immunol 2008 45 : 4073 4079
6. Tha-In T, Metselaar HJ, Tilanus HW, Groothuismink ZM, Kuipers EJ, de Man RA, Kwekkeboom J : Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells. Blood 2007 110 : 3253 3262
7. Berger M, Rosenkranz P, Brown CY : Intravenous and standard immune serum globulin preparations interfere with uptake of 125I-C3 onto sensitized erythrocytes and inhibit hemolytic complement activity. Clin Immunol Immunopathol 1985 34 : 227 236
8. Basta M, Kirshbom P, Frank MM, Fries LF : Mechanism of therapeutic effect of high-dose intravenous immunoglobulin. Attenuation of acute, complement-dependent immune damage in a guinea pig model. J Clin Invest 1989 84 : 1974 1981
9. Basta M, Langlois PF, Marques M, Frank MM, Fries LF : High-dose intravenous immunoglobulin modifies complement-mediated in vivo clearance. Blood 1989 74 : 326 333
10. Mollnes TE, Hogasen K, Hoaas BF, Michaelsen TE, Garred P, Harboe M : Inhibition of complement-mediated red cell lysis by immunoglobulins is dependent on the IG isotype and its C1 binding properties. Scand J Immunol 1995 41 : 449 456
11. Lutz HU, Stammler P, Bianchi V, Trueb RM, Hunziker T, Burger R, Jelezarova E, Späth PJ : Intravenously applied IgG stimulates complement attenuation in a complement-dependent autoimmune disease at the amplifying C3 convertase level. Blood 2004 103 : 465 472
12. Lutz HU, Stammler P, Jelezarova E, Nater M, Späth PJ : High doses of immunoglobulin G attenuate immune aggregate-mediated complement activation by enhancing physiologic cleavage of C3b in C3bn-IgG complexes. Blood 1996 88 : 184 193
13. Basta M, Van GF, Luccioli S, Billings EM, Vortmeyer AO, Baranyi L, Szebeni J, Alving CR, Carroll MC, Berkower I, Stojilkovic SS, Metcalfe DD : F(ab)'2-mediated neutralization of C3a and C5a anaphylatoxins: a novel effector function of immunoglobulins. Nat Med 2003 9 : 431 438
14. Basta M, Dalakas MC : High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J Clin Invest 1994 94 : 1729 1735
15. Rieben R, Roos A, Muizert Y, Tinguely C, Gerritsen AF, Daha MR : Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation. Blood 1999 93 : 942 951
16. Miletic VD, Hester CG, Frank MM : Regulation of complement activity by immunoglobulin. I. Effect of immunoglobulin isotype on C4 uptake on antibody-sensitized sheep erythrocytes and solid phase immune complexes. J Immunol 1996 156 : 749 757
17. van der Neut KM, Schuurman J, Losen M, Bleeker WK, Martinez-Martinez P, Vermeulen E, den Bleker TH, Wiegman L, Vink T, Aarden LA, De Baets MH, van de Winkel JG, Aalberse RC, Parren PW : Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007 317 : 1554 1557
18. Arumugam TV, Tang SC, Lathia JD, Cheng A, Mughal MR, Chigurupati S, Magnus T, Chan SL, Jo DG, Ouyang X, Fairlie DP, Granger DN, Vortmeyer A, Basta M, Mattson MP : Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci U S A 2007 104 : 14104 14109
19. Jelezarova E, Lutz HU : IgG naturally occurring antibodies stabilize and promote the generation of the alternative complement pathway C3 convertase. Mol Immunol 2005 42 : 1393 1403
20. Council of Europe : 2.6.17. Test for Anticomplementary Activity of Immunoglobulin, 6th edn. Strasbourg, France, European Pharmacopoeia, 2007 : 191 193